Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.74 USD -0.28 USD ( -3.49% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

Income Statement

Currency: USD
Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020
Revenue
Revenue
80
+137%
34
+101%
17
+350%
4
N/A
0
N/A
0
N/A
Gross Profit
Cost of Revenue
(2)
(1)
(1)
(0)
0
0
Gross Profit
78
+141%
33
+100%
16
+347%
4
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(310)
(302)
(300)
(282)
(246)
(219)
Selling, General & Administrative
(142)
(136)
(129)
(116)
(100)
(77)
Research & Development
(175)
(165)
(170)
(166)
(146)
(142)
Depreciation & Amortization
(2)
(1)
(1)
(0)
0
0
Other Operating Expenses
8
0
0
0
0
0
Operating Income
(231)
+14%
(270)
+5%
(284)
-2%
(278)
-13%
(246)
-12%
(219)
N/A
Pre-Tax Income
Interest Income Expense
13
10
26
71
(9)
(27)
Non-Reccuring Items
0
8
7
7
0
0
Total Other Income
0
0
0
1
1
1
Pre-Tax Income
(218)
+13%
(252)
0%
(251)
-26%
(200)
+21%
(254)
-3%
(246)
N/A
Net Income
Tax Provision
23
21
(1)
(0)
(0)
(0)
Income from Continuing Operations
(195)
(230)
(252)
(200)
(254)
(246)
Net Income (Common)
(195)
+15%
(230)
+9%
(252)
-26%
(200)
+21%
(254)
-3%
(246)
N/A

Balance Sheet

Currency: USD
Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020 Sep-2020 Jun-2020 Dec-2019 Jun-2019
Assets
Cash & Cash Equivalents
431
467
530
372
383
439
494
349
116
182
Cash Equivalents
431
467
530
372
383
439
494
349
116
182
Total Receivables
27
30
16
2
0
0
0
0
0
0
Accounts Receivables
27
30
16
2
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
12
11
8
8
0
0
0
0
0
0
Other Current Assets
18
17
14
13
10
11
12
11
7
3
Total Current Assets
488
525
568
394
393
451
506
359
123
185
PP&E Net
11
11
12
11
11
5
5
6
6
7
PP&E Gross
11
11
0
11
0
0
0
0
0
0
Accumulated Depreciation
2
2
0
2
0
0
0
0
0
0
Intangible Assets
14
14
13
12
10
10
10
9
8
8
Long-Term Investments
39
41
44
46
47
48
0
0
0
0
Other Long-Term Assets
31
27
1
0
0
0
0
0
0
0
Total Assets
582
-6%
618
-3%
638
+37%
464
+1%
462
-10%
514
-1%
522
+40%
374
+171%
138
-31%
201
N/A
Liabilities
Accounts Payable
16
12
12
15
12
5
6
7
3
1
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
8
8
8
7
4
5
4
4
1
1
Other Current Liabilities
47
54
40
30
26
31
23
20
16
15
Total Current Liabilities
71
74
59
52
41
40
33
31
20
17
Long-Term Debt
299
313
308
92
43
37
36
36
4
4
Other Liabilities
49
65
84
77
79
101
77
110
3
2
Total Liabilities
419
-7%
452
+0%
451
+104%
220
+35%
164
-8%
178
+22%
146
-18%
178
+570%
27
+16%
23
N/A
Equity
Common Stock
6
6
6
6
6
6
6
6
4
0
Retained Earnings
826
822
801
744
690
652
611
602
443
376
Additional Paid In Capital
982
982
982
981
981
981
981
793
550
527
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
27
Total Equity
163
-2%
166
-11%
187
-23%
244
-18%
298
-11%
336
-11%
376
+92%
196
+77%
111
-38%
178
N/A
Total Liabilities & Equity
582
-6%
618
-3%
638
+37%
464
+1%
462
-10%
514
-1%
522
+40%
374
+171%
138
-31%
201
N/A
Shares Outstanding
Common Shares Outstanding
76.8M
76.8M
76.7M
76.7M
76.7M
76.7M
76.7M
70.7M
76.7M
73.3M

Cash Flow Statement

Currency: USD
Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020 Sep-2020 Jun-2020 Dec-2019
Operating Cash Flow
Net Income
(195)
(230)
(252)
(200)
(298)
(246)
(257)
(237)
(116)
Depreciation & Amortization
3
3
3
2
3
2
2
2
2
Change in Deffered Taxes
(30)
(26)
0
0
0
0
0
0
0
Other Non-Cash Items
43
46
30
(19)
59
64
71
92
0
Cash Taxes Paid
1
1
1
0
(0)
0
0
0
0
Cash Interest Paid
6
5
4
4
3
2
2
0
0
Change in Working Capital
(33)
(26)
(5)
7
12
12
1
4
(7)
Cash from Operating Activities
(212)
+9%
(233)
-4%
(223)
-7%
(209)
+7%
(224)
-33%
(169)
+8%
(183)
-32%
(139)
-14%
(122)
N/A
Investing Cash Flow
Capital Expenditures
(7)
(6)
(7)
(6)
(3)
(3)
(2)
(1)
(2)
Other Items
(1)
(0)
0
0
(0)
(0)
0
0
(0)
Cash from Investing Activities
(7)
-12%
(7)
-1%
(7)
-16%
(6)
-63%
(3)
-23%
(3)
-19%
(2)
-145%
(1)
+57%
(2)
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
1
(2)
189
433
433
436
244
102
Net Issuance of Debt
267
267
268
49
61
62
62
62
(1)
Cash from Financing Activities
267
+0%
267
+1%
266
+12%
238
-52%
495
0%
495
0%
497
+63%
306
+205%
101
N/A
Change in Cash
Effect of Foreign Exchange Rates
(0)
0
0
0
0
0
0
(0)
0
Net Change in Cash
48
+75%
27
-24%
36
+54%
23
-91%
268
-17%
324
+4%
312
+88%
166
N/A
(23)
N/A
Free Cash Flow
Free Cash Flow
(219)
+9%
(240)
-4%
(230)
-7%
(215)
+5%
(227)
-33%
(172)
+7%
(185)
-33%
(139)
-13%
(124)
N/A

See Also

Similar Stocks